168 related articles for article (PubMed ID: 8402446)
1. Atypical adenomatous hyperplasia of the lung and its differentiation from adenocarcinoma. Characterization of atypical cells by morphometry and multivariate cluster analysis.
Mori M; Chiba R; Takahashi T
Cancer; 1993 Oct; 72(8):2331-40. PubMed ID: 8402446
[TBL] [Abstract][Full Text] [Related]
2. Atypical adenomatous hyperplasia and adenocarcinoma of the human lung: their heterology in form and analogy in immunohistochemical characteristics.
Mori M; Tezuka F; Chiba R; Funae Y; Watanabe M; Nukiwa T; Takahashi T
Cancer; 1996 Feb; 77(4):665-74. PubMed ID: 8616758
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of atypical adenomatous hyperplasia and adenocarcinoma of the lung by use of DNA ploidy and morphometric analysis.
Yokozaki M; Kodama T; Yokose T; Matsumoto T; Mukai K
Mod Pathol; 1996 Dec; 9(12):1156-64. PubMed ID: 8972475
[TBL] [Abstract][Full Text] [Related]
4. The prognosis of resected lung carcinoma associated with atypical adenomatous hyperplasia: a comparison of the prognosis of well-differentiated adenocarcinoma associated with atypical adenomatous hyperplasia and intrapulmonary metastasis.
Suzuki K; Nagai K; Yoshida J; Yokose T; Kodama T; Takahashi K; Nishimura M; Kawasaki H; Yokozaki M; Nishiwaki Y
Cancer; 1997 Apr; 79(8):1521-6. PubMed ID: 9118033
[TBL] [Abstract][Full Text] [Related]
5. Clonal growth of atypical adenomatous hyperplasia of the lung: cytofluorometric analysis of nuclear DNA content.
Nakayama H; Noguchi M; Tsuchiya R; Kodama T; Shimosato Y
Mod Pathol; 1990 May; 3(3):314-20. PubMed ID: 2362938
[TBL] [Abstract][Full Text] [Related]
6. Atypical adenomatous hyperplasia of the lung: a probable forerunner in the development of adenocarcinoma of the lung.
Mori M; Rao SK; Popper HH; Cagle PT; Fraire AE
Mod Pathol; 2001 Feb; 14(2):72-84. PubMed ID: 11235908
[TBL] [Abstract][Full Text] [Related]
7. Atypical adenomatous hyperplasia and bronchoalveolar lung carcinoma. Analysis by morphometry and the expressions of p53 and carcinoembryonic antigen.
Kitamura H; Kameda Y; Nakamura N; Inayama Y; Nakatani Y; Shibagaki T; Ito T; Hayashi H; Kimura H; Kanisawa M
Am J Surg Pathol; 1996 May; 20(5):553-62. PubMed ID: 8619420
[TBL] [Abstract][Full Text] [Related]
8. Detection and discrimination of preneoplastic and early stages of lung adenocarcinoma using hnRNP B1 combined with the cell cycle-related markers p16, cyclin D1, and Ki-67.
Tominaga M; Sueoka N; Irie K; Iwanaga K; Tokunaga O; Hayashi S; Nakachi K; Sueoka E
Lung Cancer; 2003 Apr; 40(1):45-53. PubMed ID: 12660006
[TBL] [Abstract][Full Text] [Related]
9. [Atypical adenomatous hyperplasia of the lung].
Paklina OV; Galil-Ogly GA; Bershchanskaia AM; Alipchenko LA
Arkh Patol; 2000; 62(3):21-4. PubMed ID: 10897432
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical detection of XIAP and p63 in adenomatous hyperplasia, atypical adenomatous hyperplasia, bronchioloalveolar carcinoma and well-differentiated adenocarcinoma.
Wu M; Orta L; Gil J; Li G; Hu A; Burstein DE
Mod Pathol; 2008 May; 21(5):553-8. PubMed ID: 18432259
[TBL] [Abstract][Full Text] [Related]
11. The association between atypical adenomatous hyperplasia and primary lung cancer.
Chapman AD; Kerr KM
Br J Cancer; 2000 Sep; 83(5):632-6. PubMed ID: 10944604
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of atypical adenomatous hyperplasia of the lung in autopsy specimens from elderly patients with malignant neoplasms.
Yokose T; Ito Y; Ochiai A
Lung Cancer; 2000 Aug; 29(2):125-30. PubMed ID: 10963842
[TBL] [Abstract][Full Text] [Related]
13. Proliferative activity, p53 expression and loss of heterozygosity on 3p, 9p and 17p in atypical adenomatous hyperplasia of the lung.
Kitaguchi S; Takeshima Y; Nishisaka T; Inai K
Hiroshima J Med Sci; 1998 Mar; 47(1):17-25. PubMed ID: 9583279
[TBL] [Abstract][Full Text] [Related]
14. Genetic relationship among atypical adenomatous hyperplasia, bronchioloalveolar carcinoma and adenocarcinoma of the lung.
Morandi L; Asioli S; Cavazza A; Pession A; Damiani S
Lung Cancer; 2007 Apr; 56(1):35-42. PubMed ID: 17241687
[TBL] [Abstract][Full Text] [Related]
15. The value of CT attenuation in distinguishing atypical adenomatous hyperplasia from adenocarcinoma in situ.
Jiang B; Wang J; Jia P; Le M
Zhongguo Fei Ai Za Zhi; 2013 Nov; 16(11):579-83. PubMed ID: 24229623
[TBL] [Abstract][Full Text] [Related]
16. Lung adenocarcinoma associated with atypical adenomatous hyperplasia. A clinicopathological study with special reference to smoking and cancer multiplicity.
Kitagawa H; Goto A; Niki T; Hironaka M; Nakajima J; Fukayama M
Pathol Int; 2003 Dec; 53(12):823-7. PubMed ID: 14629747
[TBL] [Abstract][Full Text] [Related]
17. Comparative ultrastructural study of atypical adenomatous hyperplasia and adenocarcinoma of the human lung.
Mori M; Kaji M; Tezuka F; Takahashi T
Ultrastruct Pathol; 1998; 22(6):459-66. PubMed ID: 9891925
[TBL] [Abstract][Full Text] [Related]
18. Atypical adenomatous hyperplasia of the lung: a clinicopathological study of 118 cases including cases with multiple atypical adenomatous hyperplasia.
Nakahara R; Yokose T; Nagai K; Nishiwaki Y; Ochiai A
Thorax; 2001 Apr; 56(4):302-5. PubMed ID: 11254822
[TBL] [Abstract][Full Text] [Related]
19. Targeted next-generation sequencing for analyzing the genetic alterations in atypical adenomatous hyperplasia and adenocarcinoma in situ.
Xu X; Li N; Zhao R; Zhu L; Shao J; Zhang J
J Cancer Res Clin Oncol; 2017 Dec; 143(12):2447-2453. PubMed ID: 28821955
[TBL] [Abstract][Full Text] [Related]
20. Molecular alterations in atypical adenomatous hyperplasia occurring in benign and cancer-bearing lungs.
Gradowski JF; Mantha GS; Hunt JL; Dacic S
Diagn Mol Pathol; 2007 Jun; 16(2):87-90. PubMed ID: 17525677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]